Skip to main content

Scientists genetically engineer a mouse that’s immune to cocaine addiction

cocaine mouse addiction mouseinsnow feat
Victor Tyakht/123RF
Scientists at the University of British Columbia have genetically engineered a mouse incapable of becoming addicted to cocaine.

“The purpose of [our] study was to understand a little bit more about the addicted brain — and specifically to understand a little more about what’s going on at the cellular and molecular level,” Dr. Shernaz Bamji, a professor in the Department of Cellular and Physiological Sciences, who worked on the project, told Digital Trends. “Researchers are pretty confident now that addiction is a form of learning that goes a bit haywire in a particular circuit in the brain. To learn you have to strengthen synaptic connections, and this involves adding more ‘glue’ — a protein called cadherin, which holds brain cells together — to the synapse.”

The researchers figured that adding more cadherin to synapses found within the brain circuit involved in addiction would lead to higher levels of addiction, since more glue should mean stronger synapses and more learned behavior, including pathological addiction.

Instead, they found the opposite.

“We have a cage with three very distinct chambers in it,” Bamji continued. “We take our [mouse] and give it cocaine and let it associate the cocaine ‘high’ with one of the three chambers. We train it this way for a number of days until it’s learned that it always feels the high in that location. When you allow the mice to freely move between the chambers, normal mice will always gravitate towards the chamber where it received the drug, which may indicate it’s looking for that high. [But] the mice which had too much glue or cadherin at synapses didn’t behave this way. They didn’t keep going to the room where they received the cocaine — they seemed to be just as happy exploring all around the cage.”

The study suggests a number of interesting things, including adding to the evidence that repetitive drug use has a lot to do with genetics and biochemistry, rather than just being something which affects “weak-willed” individuals.

It also reveals the possibility of developing possible treatments for addiction although, as lead author Dr. Andrea Globa told Digital Trends, it’s not entirely straightforward.

“Anything we can find out about how these circuits work is exciting and allows us to think about the possibility of being able to target parts of the brain with a particular drug,” Globa said. “One important thing to keep in mind is that cadherin is important in a lot of different types of learning, not just pathological addiction. So to simply target cadherin with a drug might not be the best approach because reducing someone’s ability to remember the rewarding effects of using a drug could also have negative effects on their ability to remember important things in their day-to-day life.”

Still, the more that can be learned about the proteins involved in different reward pathways, the better scientists’ ability to develop solutions to problems like addiction will be.

The work additionally opens up the possibility of one day being able to determine whether a person is predisposed to addiction by looking at their genes.

Editors' Recommendations

Luke Dormehl
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
Scientists plan to use genetically engineered mosquitoes to fight the spread of Zika virus
flashing light mosquitoes malaria tiger mosquito

If you've been paying attention to the news for the past week, you've undoubtedly heard about the recent Zika virus outbreak by now. The virus, which is currently spreading across the Americas, has been linked to a rare birth defect known as microencephaly, a condition in which infants are born with abnormally small heads and brains. Since the outbreak, there's been a sizable uptick in infants born with this condition. The World Health Organization estimates that as many as 4 million people could be infected with the virus -- and to make matters worse, there's currently no vaccine to help stop it from spreading.

But all is not lost. Biologists are taking a bold new approach to stop the virus from spreading any further. Rather than developing a new vaccine or keeping mosquito populations at bay with insecticides, biotech firm Oxitec plans to fight the spread of Zika by deploying swarms of genetically engineered mosquitoes that will prevent virus-carrying bugs from multiplying.

Read more
Scientists develop brainwave-scanning smart home system that’s controlled with thoughts
honda smart home inside us dp6v4696

Eda Akman Aydin at Gazi University in Turkey wants to make it easier for people with movement disabilities to get around their home and has a novel idea. Her team is combining EEG (brainwave scanning) technology with current smart home products to create a thought-controlled home, reports New Scientist. It sounds like a script from a science fiction movie, but the technology to build a prototype thought control system is here, and researchers like Akman Aydin are working to develop it.

Akman Aydin's system uses an EEG cap that can detect a specific brain pattern, known as P300, that appears when a person intends to do something. The cap works in conjunction with a display that shows pictures of items, such as a TV or phone, which a person might want to use. When the person sees the image they want, the brain will send out a P300 wave that is detected by the EEG cap. This signal then can trigger the smart home appliance and be used to turn on the TV, prepare the phone to dial, and more.

Read more
Scientists genetically engineer yeast to make THC and other medical marijuana chemicals
marijuana startup tradiv raises 1 million tikun olam plant

Medical marijuana is causing a stir as patients petition for access to cannabis-derived compounds for medicinal purposes, while governments worldwide seek to control the supply of the still-illegal plant. However, biochemists at the Technical University of Dortmund in Germany may have a solution to this conundrum — THC-producing yeast. These genetically-modified organisms are potentially capable of synthesizing THC, and other medically important marijuana compounds, using an affordable method which can be scaled for bulk production.

The team at the Technical University of Dortmund in Germany published the details on their THC-producing yeast in a recent issue of the scientific journal, Biotechnology Letters. The process used the gene for tetrahydrocannabinolic acid (THCA) synthase, an enzyme responsible for the production of THC, and expressed it in two strains of yeast. Using these strains, the team was able to produce small amounts of THC and cannabidiol, another medically active compound found in marijuana which is used to treat epilepsy and other diseases. With the help of THC Pharm of Frankfurt, biochemist Oliver Kayser hopes to increase production to an industrial level, while also hoping to duplicate the entire chemical pathway of THC production, not just the final stage.

Read more